Overview

Phase 2B/3 Double-blinded Placebo-controlled

Status:
Completed

Trial end date:
2019-08-22

Target enrollment:

Participant gender:

Summary

Phase 2B double-blind placebo-controlled efficacy trial of EVO100 (previously known as Amphora ® Gel) for the prevention of acquisition of urogenital Chlamydia trachomatis infection

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Evofem Inc.

Collaborator:

Clinical Research Management, Inc.